• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Sjögren’s Center

Show Search
Hide Search
  • Sjögren’s Syndrome Information
    • Diagnosis of Sjögren’s Syndrome
    • Sjögren’s Syndrome Symptoms
    • Treatment of Sjögren’s Syndrome
    • Sjögren’s Syndrome Disease Education Series
  • About the Center
    • Meet Our Team
    • Schedule An Appointment
    • Physician Referral Information
    • Directions
  • Research
  • Support the Center
  • Contact Us
Home / Research / A randomized, double-blind, placebo-controlled multicenter phase 2 dose-ranging study to assess the safety and efficacy of multiple VAY736 doses administered subcutaneously in patients with moderate to severe primary Sjögren’s Syndrome

A randomized, double-blind, placebo-controlled multicenter phase 2 dose-ranging study to assess the safety and efficacy of multiple VAY736 doses administered subcutaneously in patients with moderate to severe primary Sjögren’s Syndrome

Each day research and clinical trials are being conducted to unveil new medications, therapies and diagnostic tools for Sjögren’s syndrome and its symptoms.  The link below contains information about a Sjögren’s clinical research study (JHM IRB00138310) being held in the Baltimore, MD area.

This study includes individuals between 18-65 years of age and tests a trial drug for patients with active Sjögren’s syndrome. The study is taking place under the direction of Dr. Thomas Grader-Beck (Principal Investigator), rheumatologist and Sjögren’s syndrome specialist.

For more information about this study, please click HERE

For more information about trials currently recruiting at our center, please contact Susan Robinson, Research Program Coordinator:

  • Email: srobin95@jhmi.edu
  • Phone: 410-550-6492
Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Use of this Site

All information contained within the Johns Hopkins Jerome L. Green Sjogren’s Center website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Jerome L. Greene Sjögren’s Syndrome Center Information

  • About Us
  • Meet Our Team
  • Physician Referral Information
  • Schedule An Appointment
  • Contact
  • Directions

Dr. Alan Baer in Chair in Front of Brick Wall Discussing Sjögren’s Syndrome

In this five-part video series on Sjögren’s syndrome, Dr. Alan Baer validates those who suffer from this disease, and informs those who don’t, about the common misconceptions and challenges that Sjögren’s syndrome patients face every day.

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube
U.S. News and World Report Rankings Badge

Johns Hopkins Medicine

© 2023 Johns Hopkins Jerome L. Greene Sjogren's Syndrome Center
Patient Privacy